Literature DB >> 25348855

Indeterminate pulmonary nodules: risk for having or for developing lung cancer?

Pierre P Massion1, Ronald C Walker2.   

Abstract

This perspective discusses the report by Pinsky and colleagues, which addresses whether noncalcified pulmonary nodules identified on CT screening carry short- and long-term risk for lung cancer. We are facing challenges related to distinguishing a large majority of benign nodules from malignant ones and among those a majority of aggressive from indolent cancers. Key questions in determining individual probabilities of disease, given their history, findings on CT, and upcoming biomarkers of risk, remain most challenging. Reducing the false positives associated with current low-dose computed tomography practices and identification of individuals who need therapy and at what time during tumor surveillance could reduce costs and morbidities associated with unnecessary interventions. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25348855      PMCID: PMC4829944          DOI: 10.1158/1940-6207.CAPR-14-0364

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  56 in total

Review 1.  Early lung cancer action project: annual screening using single-slice helical CT.

Authors:  C I Henschke; D F Yankelevitz; D M Libby; D McCauley; M Pasmantier; N K Altorki; J P Smith; O S Miettinen
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation.

Authors:  D F Yankelevitz; A P Reeves; W J Kostis; B Zhao; C I Henschke
Journal:  Radiology       Date:  2000-10       Impact factor: 11.105

3.  Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application.

Authors:  J W Gurney; D M Lyddon; J A McKay
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

4.  Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.

Authors:  F R Hirsch; S A Prindiville; Y E Miller; W A Franklin; E C Dempsey; J R Murphy; P A Bunn; T C Kennedy
Journal:  J Natl Cancer Inst       Date:  2001-09-19       Impact factor: 13.506

5.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

6.  CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules.

Authors:  Claudia I Henschke; David F Yankelevitz; Rosna Mirtcheva; Georgeann McGuinness; Dorothy McCauley; Olli S Miettinen
Journal:  AJR Am J Roentgenol       Date:  2002-05       Impact factor: 3.959

7.  High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms.

Authors:  T Yokose; Y Ito; A Ochiai
Journal:  Lung Cancer       Date:  2000-08       Impact factor: 5.705

8.  The natural course of preneoplastic lesions in bronchial epithelium.

Authors:  Roderick H Breuer; Arifa Pasic; Egbert F Smit; Esther van Vliet; Anton Vonk Noordegraaf; Elle J Risse; Pieter E Postmus; Thomas G Sutedja
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

9.  The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.

Authors:  S J Swensen; M D Silverstein; D M Ilstrup; C D Schleck; E S Edell
Journal:  Arch Intern Med       Date:  1997-04-28

10.  A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.

Authors:  Stephen Lam; Jean C leRiche; Annette McWilliams; Calum Macaulay; Yulia Dyachkova; Eva Szabo; John Mayo; Robert Schellenberg; Andy Coldman; Ernest Hawk; Adi Gazdar
Journal:  Clin Cancer Res       Date:  2004-10-01       Impact factor: 12.531

View more
  11 in total

Review 1.  Biomarkers of risk to develop lung cancer in the new screening era.

Authors:  Thomas Atwater; Pierre P Massion
Journal:  Ann Transl Med       Date:  2016-04

2.  Risk models to select high risk candidates for lung cancer screening.

Authors:  Matthew B Schabath
Journal:  Ann Transl Med       Date:  2018-02

3.  Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.

Authors:  Kristin J Lastwika; Julia Kargl; Yuzheng Zhang; Xiaodong Zhu; Edward Lo; David Shelley; Jon J Ladd; Wei Wu; Paul Kinahan; Sudhakar N J Pipavath; Timothy W Randolph; Melissa Shipley; Paul D Lampe; A McGarry Houghton
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

4.  Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay.

Authors:  Neil N Trivedi; Mehrdad Arjomandi; James K Brown; Tess Rubenstein; Abigail D Rostykus; Stephanie Esposito; Eden Axler; Mike Beggs; Heng Yu; Luis Carbonell; Alice Juang; Sandy Kamer; Bhavin Patel; Shan Wang; Amanda L Fish; Zaid Haddad; Alan Hb Wu
Journal:  Biomed Res Clin Pract       Date:  2018-10-29

5.  Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules.

Authors:  Ying Liu; Yoganand Balagurunathan; Thomas Atwater; Sanja Antic; Qian Li; Ronald C Walker; Gary T Smith; Pierre P Massion; Matthew B Schabath; Robert J Gillies
Journal:  Clin Cancer Res       Date:  2016-09-23       Impact factor: 12.531

6.  A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.

Authors:  Andrew V Kossenkov; Rehman Qureshi; Noor B Dawany; Jayamanna Wickramasinghe; Qin Liu; R Sonali Majumdar; Celia Chang; Sandy Widura; Trisha Kumar; Wen-Hwai Horng; Eric Konnisto; Gerard Criner; Jun-Chieh J Tsay; Harvey Pass; Sai Yendamuri; Anil Vachani; Thomas Bauer; Brian Nam; William N Rom; Michael K Showe; Louise C Showe
Journal:  Cancer Res       Date:  2018-11-28       Impact factor: 12.701

Review 7.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

Review 8.  Artificial intelligence in cancer imaging: Clinical challenges and applications.

Authors:  Wenya Linda Bi; Ahmed Hosny; Matthew B Schabath; Maryellen L Giger; Nicolai J Birkbak; Alireza Mehrtash; Tavis Allison; Omar Arnaout; Christopher Abbosh; Ian F Dunn; Raymond H Mak; Rulla M Tamimi; Clare M Tempany; Charles Swanton; Udo Hoffmann; Lawrence H Schwartz; Robert J Gillies; Raymond Y Huang; Hugo J W L Aerts
Journal:  CA Cancer J Clin       Date:  2019-02-05       Impact factor: 508.702

9.  Indeterminate nodules in osteosarcoma: what's the follow-up?

Authors:  K M Ghosh; L H Lee; T B Beckingsale; C H Gerrand; K S Rankin
Journal:  Br J Cancer       Date:  2018-01-30       Impact factor: 7.640

10.  The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT.

Authors:  Magdy Soliman; Teresa Petrella; Pascal Tyrrell; Frances Wright; Nicole J Look Hong; Hua Lu; Petros Zezos; Laura Jimenez-Juan; Anastasia Oikonomou
Journal:  Eur J Radiol Open       Date:  2019-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.